Search
Showing results for "1"
What would you discover to help a child? At The Kids, our researchers are committed to Type 1 Diabetes research that makes a real difference.
Does eating cashew nut spreads in the first year of life reduce the chances a baby will develop a cashew nut food allergy?
News & Events
Dr Amelia Harray on ABC RadioDid you hear our head of nutrition research Dr Amelia Harray on ABC Radio recently? Listen to Amelia discuss tips to limit sugar on Halloween PLUS
Research
Variation in nutrition education practices in SWEET pediatric diabetes centers-an international comparisonNutrition education is central to pediatric type 1 diabetes management. Dietary management guidelines for type 1 diabetes are evidence based, but implementation may be challenging and inconsistent. We describe variation in the practice of nutrition education across pediatric diabetes centers globally and explore associations with A1c and BMI.
Browse the published work of the Centre's researchers
News & Events
Perth's active T1D communityDespite the unseasonal weather, good turnouts were recorded for recent events organised by PMH and Diabetes WA.
Research
Resilience and Diabetes 2 (the RAD2 study)Investigators: Anna Hunt, Ashleigh Lin Stress and anxiety are significant problems in children and adolescence with type 1 diabetes. Not only do
Research
Control of mitophagy initiation and progression by the TBK1 adaptors NAP1 and SINTBADMitophagy preserves overall mitochondrial fitness by selectively targeting damaged mitochondria for degradation. The regulatory mechanisms that prevent PTEN-induced putative kinase 1 (PINK1) and E3 ubiquitin ligase Parkin (PINK1/Parkin)-dependent mitophagy and other selective autophagy pathways from overreacting while ensuring swift progression once initiated are largely elusive.
Research
Efficacy and Safety of Epicutaneous Immunotherapy in Peanut-Allergic Toddlers: Open-Label Extension to EPITOPEThe pivotal phase 3 EPITOPE trial, a 12-month, double-blind, placebo-controlled study of epicutaneous immunotherapy with the VIASKIN patch containing 250 μg of peanut protein (VP250), previously reported significant treatment response versus placebo in peanut-allergic toddlers aged 1 through 3 years.
News & Events
Good news for studentsThe Children’s Diabetes Centre welcomes a new Federal Government initiative to support children with Type 1 Diabetes in schools. The two-year $6 million schools education and training program will be implemented at every school with a student with Type 1 Diabetes.